COVID Vaccine For Children: Covaxin Approval Requested in US For Kids Aged 2-18 | Read Details
India.com News Desk | Nov 6, 2021, 11:00 AM IST
Covaxin was evaluated in three age groups: two-six years, six-12 years and 12-18 years. All participants received two doses of the whole virion inactivated SARS-CoV-2 virus vaccine 28 days apart, added the statement from Ocugen.










